CorMedix (CRMD) Financials

$8.43

$-0.04 (-0.47%)

As on 04-Sep-2026 16:00EDT

Market cap

$657 Mln

Revenue (TTM)

$462 Mln

P/E Ratio

3.9

P/B Ratio

1.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	462.25	311.71	43.47	--	0.07	0.19
Cost of Revenue	79.61	35.96	3.19	0.21	0.00	0.15
Gross Profit	382.64	275.75	40.28	-0.21	0.06	0.04
Operating Expenses	165.60	125.61	62.64	48.75	30.69	29.48
Operating Profit (EBIT)	217.04	150.14	-22.36	-48.96	-30.62	-29.44
Other Income	--	--	--	--	--	-0.02
Profit before Tax	203.40	150.02	-19.32	-46.34	-30.29	-29.46
Provision for Tax	16.23	-13.04	-1.39	0.00	-0.59	-1.25
Profit after Tax (Net Income)	187.17	163.06	-17.93	-46.34	-29.70	-28.21
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-29.70	-28.21

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	460.83	405.31	84.66	70.14	55.06	62.80
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	255.82	246.57	0.35	0.52	0.67	0.80
Current Liabilities	187.40	174.27	33.84	11.40	6.31	5.35
Total Liabilities	1,091.45	826.14	118.85	82.06	62.04	68.95

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	423.50	459.09	4.27	2.61	2.49	2.48
Current Assets	480.55	367.05	114.58	79.45	59.55	66.47
Total Assets	1,091.45	826.14	118.85	82.06	62.04	68.95
Total Debt*	145.15	148.91	0.52	0.67	0.80	0.92
Net Current Assets	293.16	192.78	80.74	68.05	53.24	61.12

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	175.05	-50.62	-38.41	-24.36	-21.16
Cash Flow from Investing Activities	--	-308.43	21.23	-17.06	-3.71	-9.13
Cash from Financing Activities	--	238.45	26.32	55.92	17.90	41.76
Net Cash Inflow / Outflow	--	--	--	--	--	11.45

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	2.10	1.74	-0.29	-0.81	-0.71	-0.74
Cash EPS ($)	--	1.89	-0.29	-0.81	-0.71	-0.74
Adjusted Book Value ($)	--	4.32	1.38	1.22	1.32	1.65
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	1.86	-0.82	-0.67	-0.58	-0.56
Free Cash Flow per Share ($)	--	1.84	-0.82	-0.67	-0.59	-0.59

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	51.00	-22.99	-73.16	-49.68	-51.77
ROE (%)	43.22	66.56	-23.17	-74.02	-50.40	-52.72
ROA (%)	27.21	34.51	-17.85	-64.32	-45.35	-47.71
EBIT Margin (%)	46.41	49.02	-44.37	--	-46,264.70	-15,477.81
Net Margin (%)	40.49	52.31	-41.24	--	-45,409.90	-16,780.91
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	280.50	6.17	--	-1.00	-0.66	-0.20
EBIT Growth (%)	314.79	892.18	58.34	-53.02	-2.40	-8.79
Net Profit Growth (%)	265.86	1,009.40	61.31	-56.02	-5.29	-28.07
EPS Growth (%)	181.86	6.96	0.64	-0.14	0.04	-0.09
Book Value Growth (%)	62.43	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	3.88	6.70	-27.79	-4.66	-5.95	-6.15
Price / Book Value	1.46	2.69	5.89	3.08	3.21	2.76
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	2.20	6.51	-23.56	-3.04	-3.94	-3.71
Close Price ($)	7.85	11.63	8.10	3.76	4.22	4.55
High Price ($)	14.96	17.43	13.85	6.09	8.03	18.80
Low Price ($)	6.13	5.60	2.89	2.57	2.65	4.30
Market Cap ($ Cr)	657.07	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.31	0.37	0.01	0.01	0.01	0.01
Short term debt to equity ratio	--	0.00	0.00	0.00	0.00	0.00
Current Ratio	2.56	2.11	3.39	6.97	9.44	12.44
Quick Ratio	2.36	1.94	3.16	6.78	9.44	12.43
Interest Coverage	74.55	54.92	-529.83	-1,350.16	-1,141.27	-1,853.65

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	34.90	54.93	118.82	--	--	23.76
Asset Turnover	0.67	0.66	0.43	--	0.00	0.00
Receivable days	--	130.59	216.99	--	126.67	46.60
Inventory Days	--	189.50	555.56	1,871.32	147.12	179.72
Payable days	--	48.77	343.43	5,758.57	215,770.46	4,092.57
Cash Conversion Cycle	--	271.32	429.13	--	-215,496.67	-3,866.24

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.